Browsing: Weight Loss

GLP-1 weight loss tablet approval: why it matters for brokers | Insurance Business

Aug 11 (Reuters) – Hims & Hers Health’s shares fell nearly 7% in premarket trading on Tuesday, as concerns over ‌shrinking profit margins overshadowed strong subscriber growth and a raised ‌annual revenue forecast

Fractyl HealthGUTSsaid its Revita endoscopic procedure showed durable weight-maintenance results one year after patients discontinued GLP-1 therapy, while the company reaffirmed plans to report pivotal trial data in early fourth-quarter 2026 and pursue a potential FDA De Novo submission later in the year

Our bones weaken as we age, but there are things you can do to slow the process down. Your food choices can have a major impact on bone strength; your lifestyle choices including alcohol intake and smoking make a difference, and your workouts do too

A patient in Blackburn or Bolton who has spent eighteen months on a waiting list for a specialist weight management referral will not care much that a tablet approved this week can be swallowed without the ritual of fasting water and empty stomachs that governs its rivals. Convenience is not what stands between most people…

The 45-year-old ‘This Is Us’ actress said she considered several approaches before turning to medication

A new daily weight loss pill, made by the same pharmaceutical company that makes the Mounjaro jab has been approved for use in the UK

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete with rival Novo Nordisk’sWegovy pill in the U.K

A law student died in her university halls of residence after taking weight loss medication, an inquest heard

NEW YORK, Aug 10 (Reuters) – Hims & Hers Health posted a wider-than-expected second-quarter loss on Monday as the telehealth company’s shift to branded weight-loss drugs drove up costs, sending its shares down 6% in extended trading